COVID-19

Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection

Jordana JampelInfectious Disease | April 23, 2025

The universal coronavirus vaccine targets the low-mutation stalk region of the virus.

How Has COVID-19 Reshaped the World of Drug Discovery?

Christian OlsenCOVID-19 | April 4, 2025

Christian Olsen, VP of Dotmatics, describes how COVID-19 forever altered drug development timelines.

COVID-19 Infection May Increase the Risk of Heart Attack, Stroke Up to Three Years Later

Rob DillardCOVID-19 | October 9, 2024

COVID-19 infection may increase the risk of heart attack, stroke and all-cause mortality up to three years post-infection.

COVID-19 Infection Leads to Disease Progression in Children With Presymptomatic Type 1 Diabetes

Rob DillardDiabetes | July 16, 2024

COVID-19 infection accelerates disease progression in children and adolescents with presymptomatic type 1 diabetes.

Remdesivir Reduces Mortality in Elderly Patients Hospitalized With COVID-19

Jason OkuliczCOVID-19 | May 22, 2024

Jason Okulicz, of Gilead Sciences, discusses a study that showed remdesivir reduces mortality in elderly patients with COVID.

Heart Failure Patients Vaccinated Against COVID-19 Live Longer

Rob DillardHeart Failure | May 21, 2024

Heart failure patients who are vaccinated against COVID-19 have a considerably greater likelihood of living longer.

Expert Interviews on COVID-19

DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.

Get the latest medical updates and insights straight to your inbox.